Journal of Leukocyte Biology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published online as doi:10.1189/jlb.0103004 on May 22, 2003

Published online before print May 22, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0103004v1
74/2/223    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Secchiero, P.
Right arrow Articles by Zauli, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Secchiero, P.
Right arrow Articles by Zauli, G.
(Journal of Leukocyte Biology. 2003;74:223-232.)
© 2003 by Society for Leukocyte Biology

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-{alpha} promote the NF-{kappa}B-dependent maturation of normal and leukemic myeloid cells

Paola Secchiero*, Daniela Milani*, Arianna Gonelli*, Elisabetta Melloni{dagger}, Diana Campioni{ddagger}, Davide Gibellini§, Silvano Capitani*,** and Giorgio Zauli{dagger}

* Departments of Morphology and Embryology, Human Anatomy Section, and
{ddagger} Biomedical Sciences and Advanced Therapies, Hematology Section, St. Anna Hospital, University of Ferrara, Italy;
{dagger} Department of Human Normal Morphology, University of Trieste, Italy;
§ Department of Experimental and Clinical Medicine, Microbiology Section, University of Bologna, St. Orsola Hospital, Italy; and
** Interdisciplinary Center for the Study of Inflammation, University of Ferrara, Italy

Correspondence: Paola Secchiero, Ph.D., Department of Morphology and Embryology, Human Anatomy Section, University of Ferrara, Via Fossato di Mortara 66, 44100 Ferrara, Italy; E-mail: secchier{at}mail.umbi.umd.edu

Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-{alpha} induced monocytic maturation of primary normal CD34-derived myeloid precursors and of the M2/M3-type acute myeloid leukemia HL-60 cell line, associated to increased nuclear factor (NF)-{kappa}B activity and nuclear translocation of p75, p65, and p50 NF-{kappa}B family members. Consistently, both cytokines also induced the degradation of the NF-{kappa}B inhibitors, I{kappa}B{alpha} and I{kappa}B{varepsilon}, and up-regulated the surface expression of TRAIL-R3, a known NF-{kappa}B target. However, NF-{kappa}B activation and I{kappa}B degradation occurred with different time-courses, since TNF-{alpha} was more potent, rapid, and transient than TRAIL. Of the two TRAIL receptors constitutively expressed by HL-60 (TRAIL-R1 and TRAIL-R2), only the former was involved in I{kappa}B degradation, as demonstrated by using agonistic anti-TRAIL receptor antibodies. Moreover, NF-{kappa}B nuclear translocation induced by TRAIL but not by TNF-{alpha} was abrogated by z-IETD-fmk, a caspase-8-specific inhibitor. The key role of NF-{kappa}B in mediating the biological effects of TNF-{alpha} and TRAIL was demonstrated by the ability of unrelated pharmacological inhibitors of the NF-{kappa}B pathway (parthenolide and MG-132) to abrogate TNF-{alpha}- and TRAIL-induced monocytic maturation. These findings demonstrate that NF-{kappa}B is essential for monocytic maturation and is activated via distinct pathways, involving or not involving caspases, by the related cytokines TRAIL and TNF-{alpha}.

Key Words: TRAIL • TNF-{alpha} • NF-{kappa}B • myeloid cells




This article has been cited by other articles:


Home page
BloodHome page
W. Zeng, A. Miyazato, G. Chen, S. Kajigaya, N. S. Young, and J. P. Maciejewski
Interferon-{gamma}-induced gene expression in CD34 cells: identification of pathologic cytokine-specific signature profiles
Blood, January 1, 2006; 107(1): 167 - 175.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Society for Leukocyte Biology.